Date of event: estimated.The unique device identifier (udi) is unknown because the part and lot numbers were not provided.Date of implant: estimated.The devices were not returned for analysis.A review of the lot history records and complaint histories could not be conducted because the lot and part numbers were not provided.The patient effects listed are consistent with the product risk profile and are therefore expected.A conclusive cause for the difficulties listed can not be determined based on the limited information available.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling.Article, titled "the 1-year safety and efficacy outcomes of absorb bioresorbable vascular scaffolds for coronary artery disease treatment in diabetes mellitus patients: the absorb dm benelux study." the other patient events mentioned in the attached article are filed under different mfr numbers.
|
This is filed for the other patient effects: it was reported through a research article identifying the absorb bioresorbable vascular scaffold (bvs) that may be related to the following: death, myocardial infarction, restenosis, thrombosis, revascularization and re-hospitalization.Specific patient information was not provided.Details are listed in the article, titled the 1-year safety and efficacy outcomes of absorb bioresorbable vascular scaffolds for coronary artery disease treatment in diabetes mellitus patients: the absorb dm benelux study.Please see article for additional information.
|